The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety

Beginning in December of 2019, a novel coronavirus, SARS-CoV-2, emerged in China and is now a global pandemic with extensive morbidity and mortality. With the emergence of this threat, an unprecedented effort to develop vaccines against this virus began. As vaccines are now being introduced globally...

Descripción completa

Detalles Bibliográficos
Autores principales: Black, Steven B., Law, Barbara, Chen, Robert T., Dekker, Cornelia L., Sturkenboom, Miriam, Huang, Wan-Ting, Gurwith, Marc, Poland, Greg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936550/
https://www.ncbi.nlm.nih.gov/pubmed/33846042
http://dx.doi.org/10.1016/j.vaccine.2021.03.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936550/
https://www.ncbi.nlm.nih.gov/pubmed/33846042
http://dx.doi.org/10.1016/j.vaccine.2021.03.016

Ejemplares similares